)
)
Palatin Investor Relations Material
Latest events
Q2 2025
Palatin
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Palatin Technologies Inc
Access all reports
Segment Data
Access more data
Revenue by
Source
Product revenue, net
License and contract
Expenses by
Financials
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The Company's lead product candidate is bremelanotide, which is under review by the U.S. Food and Drug Administration (FDA) for the potential treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women; and the treatment of benign prostatic hyperplasia (BPH) in men. The Company has its U.S.-based headquarters and research facility located in Cranbury, New Jersey.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
PTN
Country
🇺🇸 United States